American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA.
Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
Andrology. 2019 Jul;7(4):454-462. doi: 10.1111/andr.12620. Epub 2019 Mar 29.
Testicular cancer (TC) is the most common cancer diagnosed in men of reproductive age group. Sperm banking is recommended in these patients prior to cancer treatment. There is no literature describing the proteins dysregulated in the spermatozoa of TC patients with poor motility.
The primary objective of this study was to compare the differences in the sperm proteome of normozoospermic (motility > 40%) and asthenozoospermic (motility < 40%) TC patients who had cryopreserved semen samples before initiating cancer therapy.
Pooled sperm samples from healthy fertile men (n = 8), normozoospermic (n = 20), and asthenozoospermic (n = 11) TC patients were used for quantitative global proteomic profiling by liquid chromatography-tandem mass spectrometry (LC-MS). The functional bioinformatic analysis was done by ingenuity pathway analysis software. Key differentially expressed proteins (DEPs) associated with binding of zona pellucida (CCT3), mitochondrial dysfunction (ATP5A1 and UQCRC2), sperm motility (ATP1A4), and an exosomal protein involved in the metabolic process of the spermatozoa (MMP9) were validated using Western blot analysis by comparing normozoospermic (n = 10) with asthenozoospermic (n = 10) TC patients. Statistical analysis was conducted using Mann-Whitney test.
A total of 813 and 957 proteins were detected in spermatozoa of normozoospermic and asthenozoospermic TC patients, respectively. On the other hand, 1139 proteins were detected in the spermatozoa of healthy fertile men. 198 proteins were identified as DEPs between TC patients with normal and abnormal semen parameters. Validation of DEPs revealed downregulation of key proteins (CCT3, ATP1A4, ATP5A1, and UQCRC2) implicated in the reproductive function in asthenozoospermic TC patients.
DEPs involved in the reproductive function pathways suggest defective spermatogenesis and maturation process in asthenozoospermic TC patients. Furthermore, dysfunctional exosomal pathway may be a possible cause of infertility in TC patients.
The proteins associated with sperm function and fertilization process are compromised in TC patients irrespective of their semen parameters.
睾丸癌(TC)是生殖年龄段男性中最常见的癌症。在癌症治疗前,建议这些患者进行精子库存储。目前尚无文献描述精子活力差的 TC 患者精子中失调的蛋白质。
本研究的主要目的是比较冷冻精液样本在开始癌症治疗前的正常精子活力(>40%)和弱精子活力(<40%)TC 患者的精子蛋白质组的差异。
使用来自健康生育男性(n=8)、正常精子活力(n=20)和弱精子活力(n=11)TC 患者的精子混合样本进行液质联用(LC-MS)定量全局蛋白质组学分析。功能生物信息学分析通过 Ingenuity 途径分析软件进行。通过比较正常精子活力(n=10)与弱精子活力(n=10)TC 患者,使用 Western blot 分析验证与结合透明带(CCT3)、线粒体功能障碍(ATP5A1 和 UQCRC2)、精子活力(ATP1A4)和参与精子代谢过程的外泌体蛋白(MMP9)相关的关键差异表达蛋白(DEPs)。使用 Mann-Whitney 检验进行统计分析。
正常精子活力和弱精子活力 TC 患者的精子中分别检测到 813 和 957 种蛋白质,而健康生育男性的精子中则检测到 1139 种蛋白质。在正常和异常精液参数的 TC 患者之间,鉴定出 198 种 DEPs。DEPs 的验证显示,在弱精子活力 TC 患者中,与生殖功能相关的关键蛋白(CCT3、ATP1A4、ATP5A1 和 UQCRC2)下调。
参与生殖功能途径的 DEPs 表明弱精子活力 TC 患者的精子发生和成熟过程受损。此外,功能失调的外泌体途径可能是 TC 患者不育的一个可能原因。
无论 TC 患者的精液参数如何,与精子功能和受精过程相关的蛋白质都受到了损害。